MapLight Therapeutics, Inc. MPLT Total Equity
Total Equity at other companies
Other financials
Where this comes from
Reported directly by MapLight Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:StockholdersEquity.
The official record: MapLight Therapeutics, Inc. ’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about MapLight Therapeutics, Inc. 's total equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is MapLight Therapeutics, Inc. 's total equity?
- MapLight Therapeutics, Inc. (MPLT) reported total equity of $399.83M in Q1 2026.
- How has MapLight Therapeutics, Inc. 's total equity changed year-over-year?
- MapLight Therapeutics, Inc. 's total equity increased by 285.3% year-over-year, from -$215.83M to $399.83M.
- What is the long-term trend for MapLight Therapeutics, Inc. 's total equity?
- Over 2 years (2023 to 2025), MapLight Therapeutics, Inc. 's total equity has grown at a 97.4% compound annual growth rate (CAGR), from -$117.59M to $458.37M.
- What does total equity mean?
- Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.